Novara Mark David's Form 4 filing
Tandem Diabetes Care Inc (TNDM) · filed Mar 18, 2026
- Accession no.
- 0001438133-26-000023
- Filed
- Mar 18, 2026
- Trade date
- Mar 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.31K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Novara Mark DavidCIK 0002000342 | Officer (EVP & CHIEF COMMERCIAL OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +7,414 | $0.00 | $0 | 43,383 | Direct | |
| Mar 16, 2026 | Common Stock | FTax withholdingDisposed | −5,540 | $21.59 | −$119,608.6 | 37,843 | Direct | |
| Mar 17, 2026 | Common Stock | SSaleDisposed | −187 | $23.05 | −$4,310.35 | 37,656 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −7,414 | $0.00 | $0 | 22,244 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.